免疫肿瘤学检测市场：按产品、技术、适应症、应用、地区 - 规模、份额、展望、机会分析，2022-2028 年

免疫肿瘤学作为一种通过刺激人体免疫系统来治疗癌症的新方法而备受关注。 这是对抗癌症的有力武器，因为它可以利用人体的天然防御系统来抵抗感染。 它使用患者自身的免疫系统来检测和破坏癌细胞。 免疫肿瘤学是抗癌药物治疗领域最有前途的研究领域之一。

市场动态

全球癌症负担的增加、对开发新型癌症疗法的更多关注、研发活动的增加以及免疫肿瘤学重要性的增加将导致预测期内全球免疫肿瘤学的增长。一些关键因素预计会推动生化分析市场的增长是：

例如，2021 年 4 月，罗氏宣布推出“Elecsys Anti-p53 免疫测定”，该产品支持对可用于诊断咽癌、肠癌和乳腺癌的抗 p53 抗体进行体外定量测量。。 此外，2019 年 4 月，Roche Diagnostics 将推出一种新的检测方法 VENTANA HER2 Dual ISH DNA Probe Cocktail，用于识别乳腺癌和胃癌中的人类表皮生长因子受体 2 (HER2) 生物标誌物。

这项研究的主要特点

• 本报告对全球肿瘤免疫分析市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2028) 的市场规模和復合年增长率 (CAGR%)。I'我在这里。
• 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
• 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
• 它根据以下参数（包括公司亮点、产品组合、主要亮点、财务业绩和战略）介绍了全球免疫肿瘤学检测市场的领先企业。
• 本研究涵盖的主要公司包括 Charles River、Roche、llumina 和 Agilent Technologies, Inc. 等。
• 这份报告中的见解将使营销人员和公司的高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 本研究报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球免疫肿瘤学检测市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按产品分类
  • 市场概况：按技术分类
  • 市场概况：按指示
  • 市场概况：按应用分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 全球癌症发病率上升
  • 缺乏熟练的专业人员
  • 增加研发 (R&D) 活动
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/批准
• 害虫分析
• 对 PORTER 的分析
• 合併/收购场景

第 4 章全球免疫肿瘤学检测市场：冠状病毒 (COVID-19) 大流行的影响

• COVID-19 的流行病学特征
• 供应方和需求方分析
• 经济影响

第 5 章全球免疫肿瘤学检测产品市场，2017-2028

• 消耗品
• 软件

第 6 章免疫肿瘤学检测市场：按技术分类，2017-2028

• 免疫测定
• 聚合□链反应
• 下一代测序
• 流式细胞术
• 其他

第 7 章免疫肿瘤学检测市场：按适应症分类，2017-2028

• 结肠癌
• 肺癌
• 黑色素瘤
• 膀胱癌
• 其他

第 8 章免疫肿瘤学检测市场：按应用，2017-2028

• 临床诊断剂
• 用于研究和开发

第 9 章免疫肿瘤学检测市场：地区，2017-2028

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲
• 世界其他地方

第10章竞争格局

• Charles River
• Roche
• llumina
• Agilent Technologies, Inc.

第 11 章章节

• 调查方法介绍
• 关于出版商

Immuno-oncology is emerging as a novel approach to cancer treatment through the stimulation of the body's own immune system. It is a formidable weapon against cancer as it has the ability to harness the body's natural defenses against infection. It is method that tap into the patient's own immune system to detect and destroy cancer cells. Immuno-oncology is one of the most promising areas of research in the world of anti-cancer therapeutics.

Market Dynamics:

Increase in burden of cancer across the globe, rise in focus on the development of novel cancer treatments, increase in research and development (R&D) activities, and growing significance of immuno-oncology are some major factors expected to drive growth of the global immuno-oncology assays market over the forecast period.

For instance, in April 2021, Roche announced the launch of its Elecsys Anti-p53 immunoassay to boost in vitro quantitative determination of anti-p53 antibodies to help diagnose throat, bowel, and breast cancer. Moreover, in April 2019, Roche Diagnostics announced the launch of the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for identification of human epidermal growth factor receptor 2 (HER2) biomarker in breast and gastric cancers.

Key features of the study:

• This report provides in-depth analysis of the global immuno-oncology assays market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global immuno-oncology assays market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Charles River, Roche, llumina, and Agilent Technologies, Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global immuno-oncology assays market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market.

Detailed Segmentation:

• Global Immuno-Oncology Assays Market By Product:
  • Consumables
  • Software
• Global Immuno-Oncology Assays Market By Technology:
  • Immunoassay
  • PCR
  • NGS
  • Flow Cytometry
  • Others
• Global Immuno-Oncology Assays Market By Indication:
  • Colorectal Cancer
  • Lung Cancer
  • Melanoma
  • Bladder Cancer
  • Others
• Global Immuno-Oncology Assays Market By Application:
  • Clinical Diagnostics
  • Research and Development
• Global Immuno-Oncology Assays Market By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Charles River
  • Roche
  • Llumina
  • Agilent Technologies, Inc.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Technology
  • Market Snapshot, By Indication
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in burden of cancer across the globe
  • Dearth of skilled professionals
  • Increase in research and development (R&D) activities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Immuno-Oncology Assays Market, By Product, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Immuno-Oncology Assays Market, By Technology, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• PCR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• NGS
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Flow Cytometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Immuno-Oncology Assays Market, By Indication, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Colorectal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Lung Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Melanoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Bladder Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Immuno-Oncology Assays Market, By Application, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Clinical Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Research and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

9. Immuno-Oncology Assays Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

10. Competitive Landscape

• Charles River
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• llumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us